GENTILI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 1.439
EU - Europa 351
AS - Asia 104
AF - Africa 39
SA - Sud America 3
Totale 1.936
Nazione #
US - Stati Uniti d'America 1.412
SE - Svezia 104
IT - Italia 83
DE - Germania 69
IN - India 59
CN - Cina 44
FI - Finlandia 34
BJ - Benin 33
UA - Ucraina 21
AT - Austria 17
CA - Canada 14
GB - Regno Unito 11
BZ - Belize 9
TG - Togo 5
BE - Belgio 4
MX - Messico 4
AR - Argentina 3
IE - Irlanda 3
RO - Romania 3
KR - Corea 1
NL - Olanda 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 1.936
Città #
Fairfield 250
Woodbridge 118
Chandler 98
Ashburn 97
Seattle 92
Cambridge 80
Wilmington 62
Ann Arbor 58
Houston 58
Dearborn 54
Princeton 46
San Jose 40
Fasano 33
Frankfurt am Main 33
Plano 33
San Paolo di Civitate 32
Bremen 27
Beijing 19
Lawrence 17
Millbury 17
Washington 17
Boston 16
San Mateo 16
Vienna 16
Dallas 15
San Diego 14
Rome 13
Ottawa 11
Fremont 10
Jacksonville 10
Saint Louis 10
Belize City 9
Auburn Hills 8
Boardman 7
Hefei 7
Norwalk 7
Chicago 6
Des Moines 6
Lomé 5
Andover 4
Brussels 4
Columbus 4
Falls Church 4
Grafing 4
Dublin 3
Federal 3
Toronto 3
Atlanta 2
Indiana 2
Los Angeles 2
Mexico City 2
Nanchang 2
Ningbo 2
Taizhou 2
Torre del Greco 2
Zhengzhou 2
Augusta 1
Baotou 1
Berlin 1
Changsha 1
Chaoyang 1
Chengdu 1
Fuzhou 1
Guangzhou 1
Helsinki 1
Jinan 1
Kenmore 1
Lanzhou 1
Leawood 1
London 1
Muizenberg 1
Nanjing 1
Provo 1
Redwood City 1
Sacramento 1
Sesto Fiorentino 1
Southend 1
Xian 1
Totale 1.536
Nome #
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation 97
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 86
Does nutritional status influence the outcome in patients undergoing liver transplantation in the “MELD” era? 81
Chronic renal dysfunction after liver transplantation: Incidence and risk factors 78
Predictive Factors of Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Multivariate Analysis 78
PREDICTIVE RISK FACTORS OF RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION 73
One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation 72
COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN (HBIG) AND LAMIVUDINE (LAM) IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE: LONG TERM EFFICACY AND COSTS 72
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 72
EFFECT OF RIBAVIRIN PRE-TREATMENT ON EARLY VIROLOGICAL RESPONSE OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 71
THE PREDICTION OF CHRONIC RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION: A TIME-DEPENDENT ANALYSIS 70
Predictors of outcome of liver transplantation in patients with liver cirrhosis and hepatocellular carcinoma 68
Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation 68
VALIDATION OF A PREDICTIVE MODEL FOR CHRONIC RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION 66
Nutritional status: its influence on the outcome of patients undergoing liver transplantation 66
Hepatic steatosis after liver transplantation: Prevalence and associated factors 64
Short-term changes in nutritional status, energy expenditure, dietary intake in patients undergoing liver transplantation 64
ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION 63
Ribavirin priming improves the virological response to antiviral treatment in transplanted patients with recurrent hepatitis C: a pilot study 62
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma 61
Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis c: Allo or autoimmune de novo hepatitis? 59
SHORT TERM EFFECTS OF CONVERSION FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS FORMULATION IN LIVER TRANSPLANT PATIENTS 57
Molecular mechanisms underlying muscle loss in cirrhotic patients 53
SEQUENTIAL CHANGES IN NUTRITIONAL STATUS, ENERGY EXPENDITURE, DIETARY INTAKE DURING THE FIRST SIX MONTHS AFTER LIVER TRANSPLANTATION 51
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma 50
Estrado de nutrition, composicion corporal y metabolismo energetico en pacientes con cirrosis epatica 48
AUTOIMMUNE DE NOVO HEPATITIS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION 45
AUTOIMMUNE DE NOVO HEPATITIS IN TRANSPLANTED PATIENTS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE 43
Actualidad en la pathogenesis y tratamiento de la encefalopatia epatica 41
SUCCESSFUL COMBINED LONG TERM PROPHYLAXIS WITH LAMIVUDINE AND LOW DOSE HEPATITIS B IM IMMUNOGLOBULIN IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE. 38
CALCINEURIN INHIBITORS REDUCTION IN LIVER TRANSPLANTED PATIENTS WITH CHRONIC RENAL DYSFUNCTION: RESULTS IN CURRENT CLINICAL PRACTICE 37
SUCCESSFUL COMBINED LONG TERM PROPHYLAXIS WITH LAMIVUDINE AND LOW DOSE HEPATITIS B IM IMMUNOGLOBULIN IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE 29
FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 27
Totale 2.010
Categoria #
all - tutte 3.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019238 0 0 0 0 0 0 0 1 2 45 109 81
2019/2020650 67 16 5 18 48 259 74 53 57 26 18 9
2020/2021136 17 21 7 12 1 4 2 13 13 8 2 36
2021/2022363 1 12 34 15 50 13 3 31 50 28 47 79
2022/2023441 67 83 38 96 42 35 14 12 38 7 7 2
2023/202448 8 17 23 0 0 0 0 0 0 0 0 0
Totale 2.010